NCT05809635View on ClinicalTrials.gov

Study of BEST1 Vitelliform Macular Dystrophy

RecruitingOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

March 30, 2021

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Best Vitelliform Macular DystrophyRetinitis Pigmentosa
Interventions
OTHER

Natural History Study

Longitudinal assessment of participants with BEST1 Vitelliform Macular Dystrophy

Trial Locations (3)

10032

RECRUITING

Columbia University Irving Medical Center, New York

Unknown

NOT_YET_RECRUITING

Institut de la Vision/Centre de maladies rares du Centre Hospitalier National Ophtalmologique des Quinze-Vingts, Paris

RECRUITING

Eberhard Karls University Tubingen, Tübingen

All Listed Sponsors
collaborator

Universität Tübingen

OTHER

collaborator

Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

OTHER

collaborator

National Eye Institute (NEI)

NIH

lead

Columbia University

OTHER